List of insiders holdings for Cogent Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| FMR LLC See Remark 1 | 2024-11-07 09:24:55 | 13,208,972 0 | 13,208,972 | Form 13G |
| Venrock Healthcare Capital Partners III L.P. Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Co-Investment Holdings III LLC VHCP Management II LLC VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 2024-11-14 17:47:15 | 11,516,667 0 | 11,516,667 | Form 13G |
| Fairmount Funds Management LLC Director | 2024-06-13 06:06:27 | 11,330,141 0 | 11,330,141 | Form 13D |
| CAMPANA DARIO 10% Owner | 2020-10-08 17:43:40 | 0 3,095,114 | 3,095,114 | Form 4 |
| FIL Ltd See Remark 1 | 2018-04-05 12:28:39 | 1,138,274 0 | 1,138,274 | Form 4 |
| Robbins Andrew R President and CEO | 2024-01-25 16:20:02 | 1,100,000 0 | 1,100,000 | Form 4 |
| Atlas Venture Fund IX L.P. Atlas Venture Associates IX L.P. Atlas Venture Associates IX LLC 10% Owner | 2022-01-25 11:32:52 | 916,196 0 | 916,196 | Form 13G |
| Stamoulis Christiana President & C.F.O. | 2018-03-28 20:56:08 | 727,498 0 | 727,498 | Form 3 |
| Pinnow Cole Chief Commercial Officer | 2024-05-29 16:03:03 | 525,000 0 | 525,000 | Form 4 |
| Robinson John Edward Chief Scientific Officer | 2024-01-25 16:36:41 | 300,000 0 | 300,000 | Form 4 |
| Sachs Jessica Chief Medical Officer | 2024-01-25 16:20:10 | 300,000 0 | 300,000 | Form 4 |
| Green John L. Chief Financial Officer | 2024-01-25 16:17:30 | 300,000 0 | 300,000 | Form 4 |
| Kearns Evan Chief Legal Officer | 2024-01-25 16:27:09 | 255,000 0 | 255,000 | Form 4 |
| WILSON CHARLES Chief Executive Officer | 2019-04-11 16:41:17 | 174,400 0 | 174,400 | Form 4 |
| Osborne Matthew Scott Chief Financial Officer | 2020-02-13 16:55:34 | 160,400 0 | 160,400 | Form 4 |
| Ettenberg Seth Chief Scientific Officer | 2020-02-13 16:53:05 | 153,600 0 | 153,600 | Form 4 |
| HODGE GEOFFREY Chief Technical Officer | 2020-02-13 16:54:36 | 112,400 0 | 112,400 | Form 4 |
| VASCONCELLES MICHAEL Chief Medical Officer | 2019-04-11 16:39:28 | 61,900 0 | 61,900 | Form 4 |
| Booth Bruce Director | 2020-07-06 16:52:47 | 61,338 0 | 61,338 | Form 4 |
| Morris Arlene Director | 2024-06-13 19:06:46 | 44,700 0 | 44,700 | Form 4 |
| Shegog Todd Director | 2024-06-13 19:07:34 | 44,700 0 | 44,700 | Form 4 |
| Harwin Peter Evan Director | 2024-06-13 19:11:20 | 44,700 0 | 44,700 | Form 4 |
| Ros Matthew Director | 2024-06-13 19:14:34 | 44,700 0 | 44,700 | Form 4 |
| CAIN CHRISTOPHER W. Director | 2024-06-13 19:18:50 | 44,700 0 | 44,700 | Form 4 |
| Aldag Jorn Director | 2020-07-06 16:15:14 | 40,090 0 | 40,090 | Form 4 |
| Ratcliffe Liam Director | 2019-06-18 16:27:45 | 7,881 0 | 7,881 | Form 4 |
| PEREZ ROBERT J Director | 2019-06-18 16:25:37 | 7,131 0 | 7,131 | Form 4 |
| Ferrante Karen Jean Director | 2024-10-02 16:14:19 | 2,034 0 | 2,034 | Form 4 |